• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis of agonist-agonist interactions: the crucial influence of curve shape.

作者信息

Scaramellini C, Bennett G, Leff P

机构信息

Department of Pharmacology, Astra Charnwood, Loughborough, Leics, England.

出版信息

J Pharmacol Toxicol Methods. 1997 Apr;37(3):167-78. doi: 10.1016/s1056-8719(97)00015-4.

DOI:10.1016/s1056-8719(97)00015-4
PMID:9253753
Abstract

The two-receptor:one-transducer model (Leff, 1987) is here extended to analyze interactions between agonists displaying E[A] curves of different shapes, by incorporating slope factors into the separate and common parts of the transduction pathway. Interactions were modelled as the effect of one agonist, at fixed concentration, on the curve to the other. A variety of patterns of position and slope changes are predicted. These do not depend on the shape of the control curve, rather, they depend on the slope factors in the separate and common pathways. The following specific predictions are made: (1) when the common pathway is steep, curves undergo potentiation and flattening; (2) when the common pathway is flat, curves undergo right-shift and steepening; (3) when the common pathway is hyperbolic, curves undergo right-shift, with no slope change; (4) when the slope depends on the separate pathways, curves only undergo right-shift with no change in slope. The model provides a sound basis for classifying agonist interactions and for detecting additional, synergistic or antagonistic properties. This analysis indicates that methods based on dose-additivity or independence are less reliable for these purposes. The model provides a practical test, based on slope changes, to detect and quantify additional properties.

摘要

相似文献

1
Analysis of agonist-agonist interactions: the crucial influence of curve shape.
J Pharmacol Toxicol Methods. 1997 Apr;37(3):167-78. doi: 10.1016/s1056-8719(97)00015-4.
2
Receptor-agonist interactions in service-theoretic perspective, effects of molecular timing on the shape of dose-response curves.从服务理论角度看受体-激动剂相互作用,分子时间对剂量反应曲线形状的影响。
J Recept Signal Transduct Res. 2006;26(1-2):1-34. doi: 10.1080/10799890500391279.
3
The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.亲和力、效力和斜率因素对受体反应性方法(RRM)获得的估计值的影响:一项计算机模拟研究。
Can J Physiol Pharmacol. 2010 Nov;88(11):1061-73. doi: 10.1139/y10-078.
4
Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.浓度-反应曲线不对称性对受体反应性方法(RRM)获得结果的影响:一项计算机研究。
Can J Physiol Pharmacol. 2010 Nov;88(11):1074-83. doi: 10.1139/y10-089.
5
Simple pA2 estimation of partial agonists: comparison with the Kaumann-Blinks method.部分激动剂的简单pA2估计:与考曼-布林克斯方法的比较。
J Pharmacol Methods. 1988 Mar;19(1):47-56. doi: 10.1016/0160-5402(88)90044-7.
6
Estimation of agonist affinity, using the slope of the concentration-effect curve: comment on the method of Calderone and Martinotti.使用浓度-效应曲线斜率估算激动剂亲和力:评卡尔德龙和马蒂诺蒂的方法
J Pharmacol Toxicol Methods. 1998 Nov;40(4):241-3. doi: 10.1016/s1056-8719(99)00011-8.
7
Analysis of allosterism in functional assays.功能测定中变构作用的分析。
J Pharmacol Exp Ther. 2005 Nov;315(2):740-54. doi: 10.1124/jpet.105.090886. Epub 2005 Jul 26.
8
Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells.
Brain Res. 1998 Sep 21;806(1):26-35. doi: 10.1016/s0006-8993(98)00697-0.
9
Quantitative estimation of potentiation and antagonism by dose ratios corrected for slopes of dose-response curves deviating from one.
J Pharmacol Toxicol Methods. 1995 Aug;33(4):197-204. doi: 10.1016/1056-8719(95)00016-b.
10
Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.正变构调节剂的筛选:以调节剂浓度-效应曲线评估作为一种筛选模式
J Biomol Screen. 2007 Aug;12(5):668-76. doi: 10.1177/1087057107301854. Epub 2007 May 3.

引用本文的文献

1
A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro.体内和体外药效学药物-药物相互作用性质的机制评估。
In Silico Pharmacol. 2023 Oct 27;11(1):31. doi: 10.1007/s40203-023-00168-y. eCollection 2023.
2
Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.定量系统药理学分析药物组合及人体外推:去甲肾上腺素和血管加压素在血管收缩中的相互作用。
Br J Pharmacol. 2018 Aug;175(16):3394-3406. doi: 10.1111/bph.14385. Epub 2018 Jul 10.
3
Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
利用细胞内钙离子变化对中国仓鼠肺细胞中表达的人重组α(2A)-肾上腺素能受体进行表征:重组α(2A)-与天然α(1)-肾上腺素能受体之间存在相互作用的证据
Br J Pharmacol. 2000 Apr;129(7):1339-46. doi: 10.1038/sj.bjp.0703184.